Malaysia Urges Support for Tobacco and Smoking Control Act

Aug.01.2022
Malaysia Urges Support for Tobacco and Smoking Control Act
Malaysia aims to curb addiction to cigarettes and e-cigarettes to prevent drug abuse and protect public health.

Kuala Lumpur: Addiction to cigarettes and e-cigarettes can pave the way for drug abuse habits, and it is important to curb drug abuse from the very beginning. Therefore, all parliamentary members are urged to support the 2022 Tobacco and Smoking Products Control Bill to ensure public health and protect people from the harmful effects of these products.


The Chairperson of the National Women, Family, and Fire Department is Datuk Jamilah Baba.


Datin Jamilah Bakar, the chairwoman of Malaysia's National Association for Drug Prevention (PEMADAM) and the Women, Family and Community Development Ministry, has stated that it is high time for the country to introduce specific legislation concerning tobacco products and smoking habits, rather than relying on the Food Act and Tobacco Products Control Regulations of 1983.


PEMADAM fully supports the 2022 Tobacco Products and Smoking Control Act, as well as the implementation of the Generasi End Smoking (GEG) provisions, which prohibit smoking and purchasing cigarettes, including electronic cigarettes, for individuals born after January 1, 2007. In a statement released today, PEMADAM stated, "We recognize that smoking and e-cigarette use are gateway behaviors to drug abuse. It is necessary to curb the habit of addiction to nicotine and related substances from the very beginning.


The Tobacco Products and Smoking Control Act of 2022 is a law that regulates the registration of tobacco products, smoking materials or tobacco alternatives. It also monitors advertising, promotion, sponsorship, sales, and purchases of tobacco products, smoking materials, tobacco alternatives, and smoking devices. The law emphasizes a ban on anyone born after 2007 from smoking any tobacco product or alternative, as well as banning the use of smoking devices.


Jamela further commented that the emergence of new smoking products such as electronic cigarettes has had a negative impact on health. She stated that this would continue to burden the country's healthcare system and further threaten the health of both smokers and non-smokers.


It is estimated that by 2030, the cost of treating inflammatory lung disease (EVALI) will reach RM369 million.


According to the 2016 Malaysian Adolescent Tobacco and E-cigarette Survey (TECMA) by the Public Health Institute, 330,000 individuals, or 15.2% of adolescents aged 13 to 17 (27.8% male and 2.6% female), are electronic cigarette (e-cigarette) users.


According to Jamella, the usage of adult e-cigarettes and e-cigarette users increased from 3.2% in 2016 to 4.9% in 2019. When calculated based on the total population, the number of e-cigarette users doubled in just three years, from 600,000 to 1.2 million people.


This article is a compilation of information from third-party sources, provided for educational and informative purposes only. The copyright for the compiled information belongs to the original media and authors. If any infringement is found, please contact us to remove the content.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Philip Morris Japan Unveils TEREA “Blossom Pearl” for IQOS ILUMA
Philip Morris Japan Unveils TEREA “Blossom Pearl” for IQOS ILUMA
Philip Morris Japan announced that it will launch “TEREA Blossom Pearl,” a new tobacco stick for IQOS ILUMA, on May 11. The new product will expand the TEREA lineup to 27 variants. It features a capsule menthol flavor with strawberry and subtle herbal notes and is priced at JPY 620, or about USD 4.14 based on an assumed rate of 1 JPY = 0.00668 USD. The exchange-rate source should be verified and added.
Apr.28 by 2FIRSTS.ai
FDA Posts Environmental Assessment for Nicotine Pouches, May Influence Future PMTA Reviews
FDA Posts Environmental Assessment for Nicotine Pouches, May Influence Future PMTA Reviews
The U.S. Food and Drug Administration released a programmatic environmental assessment covering nicotine pouches and other oral nicotine products, concluding that their overall environmental impact is generally minimal.
Regulations
May.22
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
AIR Shares Drop 18.6% in Nasdaq Debut, Testing Hookah’s Move Toward Public Markets
AIR Shares Drop 18.6% in Nasdaq Debut, Testing Hookah’s Move Toward Public Markets
AIR Global’s Nasdaq debut under ticker AIIR ended with a 18.6% first-day decline, giving the global hookah industry a rare public-market reference point. Beyond one company’s share move, the listing raises a broader question: can a culturally rooted, fragmented and venue-based category evolve into a more scalable and investable consumer sector?
Special Report
May.19
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Shunhao Shares Reports 2025 Revenue of RMB 1.188 Billion, While Q1 2026 Net Profit Rises 49.94% and New Tobacco Operations Continue
Shunhao Shares Reports 2025 Revenue of RMB 1.188 Billion, While Q1 2026 Net Profit Rises 49.94% and New Tobacco Operations Continue
Shunhao Shares’ 2025 annual report summary and first-quarter 2026 report show that the company recorded 2025 revenue of RMB 1.188 billion, down 21.78% year on year, while net profit attributable to shareholders rose 30.00% to RMB 58.94 million. In the first quarter of 2026, revenue was RMB 291.51 million, down 10.34% year on year, while attributable net profit rose 49.94% to RMB 19.98 million.
Apr.29 by 2FIRSTS.ai